Andreessen Horowitz

Juniper develops a behavioral health practice management software designed to streamline the logistical operations of clinics. The platform integrates various functions, including patient onboarding and billing, into a single cohesive system. It focuses on reducing manual tasks that clinicians typically encounter, thereby enhancing efficiency. Additionally, Juniper's software emphasizes compatibility with third-party applications, allowing for better automation and accountability across clinic operations. This holistic approach enables clinics to improve their reporting capabilities and manage their databases more effectively, ultimately supporting their growth and operational scalability.

Echo Neurotechnologies is a company that specializes in the development of brain-machine interfaces. These interfaces allow patients to control external devices using only their thoughts, restoring a degree of independence and communication to those with severe disabilities. The company's primary focus is on creating neuroscience products that can significantly improve the quality of life for its users.

Counsel Health helps patients to get access to medical advice virtually.

Alchemy creates and implements clinical pharmacy programs and deploys technology products that use the pharmacy to expand access for patients, improve health outcomes, and increase the financial impact of a clinic's pharmacy program.

Scribenote is a technology company specializing in AI-driven medical scribe solutions for veterinarians. Its platform automates and simplifies the documentation process, reducing administrative tasks and allowing veterinarians to focus more on patient care. The system captures audio, generates transcripts, and creates SOAP notes during appointments, integrating seamlessly with practice management software. This streamlines workflows, enhances client experience, and improves overall efficiency in veterinary clinics.

GC Therapeutics employs synthetic biology to transform patient-derived stem cells into diverse cell types efficiently and at scale. The company has validated its technology across multiple applications, creating SuperCells™ tailored for specific conditions. Originally developed in Professor George Church's lab at Harvard Medical School, GC Therapeutics is dedicated to bringing this innovative method to patients.

IDRx is a clinical-stage biopharmaceutical company focused on developing precision therapies for oncology, specifically targeting gastrointestinal stromal tumors. The company specializes in designing precision combination therapies that utilize engineered drug combinations to address key tumor escape mechanisms and enhance the duration of therapeutic responses. Through its innovative approach, IDRx aims to transform cancer treatment by enabling healthcare professionals to create targeted cancer medicines tailored to individual patient needs.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Thyme Care is a healthcare company specializing in oncology care management services. It offers an integrated solution for patients and providers, partnering with health plans to deliver comprehensive, personalized support to cancer patients.

Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.

Pomelo Care specializes in evidence-based maternity care, supporting women from preconception through their infant's first year. It offers a unique blend of virtual, round-the-clock clinical care and in-person doula support, addressing medical, behavioral, and social factors to improve maternal and infant health outcomes.

Santa Ana Bio is a biotechnology company specializing in the development of precision immunology therapies for autoimmune diseases. It employs advanced multi-omics platforms and antibody engineering techniques to design targeted biologics, aiming to improve patient outcomes and quality of life.

Founded in 2017 by Dr. Matthew Hill, Elegen is a biotechnology company specializing in microfluidic technology for the development of advanced DNA synthesizers. Its mission is to accelerate biomedical progress through innovative synthetic biology solutions.

Milu Health is a healthcare platform focused on simplifying and reducing the costs associated with medical care for employees. By leveraging electronic health records, claims, and pricing data, the company identifies cost-saving opportunities in healthcare. Milu Health provides price transparency data that helps users find high-quality, reasonably-priced doctors and hospitals for common procedures and surgeries. This enables patients to make informed decisions regarding their healthcare, ultimately leading to savings on doctor visits, procedures, prescription drugs, and medical bills.

Ambience Healthcare is a developer of an advanced artificial intelligence-powered medical scribe that aims to enhance clinician efficiency and alleviate burnout. Its Ambience AI operating system features a suite of synergistic applications designed to capture the nuances of clinician-patient conversations in real-time, generating comprehensive notes that integrate seamlessly into electronic medical record workflows. The system employs state-of-the-art speech recognition and custom-built AI to produce documentation in seconds while accommodating individual clinician preferences to reflect their unique style and voice. By utilizing Ambience's technology, healthcare systems can significantly reduce documentation time by an average of 78%, improve coding integrity, and achieve substantial returns on investment, ultimately enabling clinicians to close all their charts by the end of their shifts and achieve a better work-life balance.

Fortuna Health specializes in simplifying Medicaid access for consumers. Its core business is a user-friendly platform that guides individuals through the complexities of eligibility, enrollment, and renewal processes, ensuring they maintain continuous coverage and receive timely notifications for recertification and renewal. This streamlined approach helps reduce care gaps and ensures clients are enrolled in the most suitable medical plan programs.

Waymark is a healthcare company focused on improving access to and quality of care for Medicaid beneficiaries. It delivers community-based services and collaborates with primary care providers to enhance access and health outcomes for patients enrolled in Medicaid. The company provides health plans, insulin education, and training, and creates employment opportunities for community-based care teams, supporting coordinated care and patient engagement so beneficiaries can monitor and manage their health.

Mana.bio is an AI-driven company specializing in drug delivery for gene therapies, including DNA and RNA-based treatments, and vaccines. It employs machine learning and nanotechnology to develop lipid nanoparticle formulations.

Inceptive specializes in designing RNA molecules using large-scale deep learning algorithms, combined with high-throughput experiments. Their platform enables the creation of novel medicines and biotechnologies, making advanced biological software more accessible.

Thyme Care is a healthcare company specializing in oncology care management services. It offers an integrated solution for patients and providers, partnering with health plans to deliver comprehensive, personalized support to cancer patients.

Founded in 2019, Genesis Therapeutics is a biotechnology company based in South San Francisco, California. It specializes in developing small molecule drug candidates for treating debilitating disorders using artificial intelligence-driven platforms.

Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations.

Pomelo Care specializes in evidence-based maternity care, supporting women from preconception through their infant's first year. It offers a unique blend of virtual, round-the-clock clinical care and in-person doula support, addressing medical, behavioral, and social factors to improve maternal and infant health outcomes.

Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

Function Oncology is a precision medicine company focused on transforming cancer treatment through its innovative CRISPR-powered personalized functional genomics platform. This platform enables the identification of therapeutic opportunities tailored to individual patients, allowing for a deeper understanding of cancer at a patient-specific level. By leveraging advanced genomic techniques, Function Oncology aims to develop targeted cancer therapies that address the unique characteristics of each patient's disease, ultimately advancing the future of cancer care.

Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Pearl Health empowers primary care providers to deliver proactive healthcare, reducing total cost of care. Founded in 2020, it partners with thousands of providers across 44 states, offering a platform that enables fixed payments per member, clinical insights, and direct contracting assistance.

Founded in 2016, Firefly Health delivers AI-driven virtual-first primary care. Its platform connects patients with healthcare professionals for convenient, continuous care, focusing on common conditions and women's health issues.

Revero is an online clinic specializing in treating chronic conditions through a root-cause approach. It offers personalized treatments for autoimmune and metabolic conditions via nutrition therapy and remote medical care, aiming to improve patients' blood sugar levels, metabolic health, reduce inflammation, and restore gut health.

Incredible Health, Inc. is a technology company based in San Francisco that operates a platform designed to connect healthcare providers, particularly hospitals, with qualified nursing professionals. Established in 2015 and originally known as Lift League, the company focuses on addressing staffing challenges in the healthcare sector. Its online recruitment platform employs AI technology to match healthcare systems with experienced nurses seeking permanent positions, particularly for hard-to-fill roles. The platform also features a subscription-based job portal that allows users, including new graduates and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Through its services, Incredible Health aims to enhance the employment experience for healthcare professionals and support healthcare organizations in fulfilling their staffing needs.

IDRx is a clinical-stage biopharmaceutical company focused on developing precision therapies for oncology, specifically targeting gastrointestinal stromal tumors. The company specializes in designing precision combination therapies that utilize engineered drug combinations to address key tumor escape mechanisms and enhance the duration of therapeutic responses. Through its innovative approach, IDRx aims to transform cancer treatment by enabling healthcare professionals to create targeted cancer medicines tailored to individual patient needs.

Cartography Biosciences specializes in developing precision cancer immunotherapies. It employs single-cell analysis to identify novel targets for Chimeric Antigen Receptor T-cell (CAR-T) therapies, aiming to enhance safety and efficacy.

Founded in 2018, Tomorrow Health operates an online marketplace for medical supplies and equipment. It connects providers, health plans, and suppliers to ensure patients receive necessary products and care at home.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.

Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

Topography Health facilitates private practice physicians' involvement in clinical trials. It assists practices in understanding patient populations, recommends suitable studies, recruits patients, and manages research staff, making personalized clinical trials more accessible.

Nitra is a financial technology company focused on transforming the healthcare industry through innovative and efficient solutions. It provides a suite of machine learning-powered financial software that includes credit cards, loans, accounts, payments, and expense management tools specifically designed for medical professionals. Nitra's platform enables healthcare providers to streamline their financial operations, allowing them to balance patient care with practice management. Its offerings include a business card that rewards spending and fosters partnerships with various service providers, as well as user-friendly accounting and receipt reconciliation tools. Nitra is committed to equipping the healthcare sector with advanced technology and dedicated support, ensuring that financial management can be both effective and straightforward.

Waymark is a healthcare company focused on improving access to and quality of care for Medicaid beneficiaries. It delivers community-based services and collaborates with primary care providers to enhance access and health outcomes for patients enrolled in Medicaid. The company provides health plans, insulin education, and training, and creates employment opportunities for community-based care teams, supporting coordinated care and patient engagement so beneficiaries can monitor and manage their health.

Founded in 2017 by Dr. Matthew Hill, Elegen is a biotechnology company specializing in microfluidic technology for the development of advanced DNA synthesizers. Its mission is to accelerate biomedical progress through innovative synthetic biology solutions.

Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.

Thyme Care is a healthcare company specializing in oncology care management services. It offers an integrated solution for patients and providers, partnering with health plans to deliver comprehensive, personalized support to cancer patients.

Pearl Health empowers primary care providers to deliver proactive healthcare, reducing total cost of care. Founded in 2020, it partners with thousands of providers across 44 states, offering a platform that enables fixed payments per member, clinical insights, and direct contracting assistance.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Pomelo Care specializes in evidence-based maternity care, supporting women from preconception through their infant's first year. It offers a unique blend of virtual, round-the-clock clinical care and in-person doula support, addressing medical, behavioral, and social factors to improve maternal and infant health outcomes.

Founded in 2016, Bayesian Health offers an AI-driven platform that integrates with hospital EMR systems. It provides real-time, actionable insights to healthcare teams by analyzing multi-layered clinical data sets, enabling timely decisions and improving patient care efficiency.

Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Nautilus Biotechnology is a life sciences company developing platform technology to quantify and unlock the complexity of the human proteome. It aims to revolutionize proteomics, accelerate drug development, and improve healthcare management by democratizing access to the proteome.

Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

Founded in 2018, Dyno Therapeutics specializes in developing adeno-associated virus (AAV) vectors for in vivo gene therapy delivery. The company's proprietary platform combines DNA synthesis of AAV capsids with sequencing and machine learning to create novel vectors tailored for safe, efficient, and targeted therapeutic solutions.

Founded in 2018, Tomorrow Health operates an online marketplace for medical supplies and equipment. It connects providers, health plans, and suppliers to ensure patients receive necessary products and care at home.

Founded in 2016, Firefly Health delivers AI-driven virtual-first primary care. Its platform connects patients with healthcare professionals for convenient, continuous care, focusing on common conditions and women's health issues.

Founded in 2018, Scribe Therapeutics specializes in engineering and developing in vivo therapies based on CRISPR technology to rewrite and repair genetic disorders. Its proprietary platform, X-Editing (XE), enables greater efficacy, specificity, and deliverability compared to existing CRISPR technologies.

Biodock is a developer of a cloud-based analysis platform that specializes in the analysis and storage of biological data, particularly microscopy images. Its innovative technology automates what traditionally takes months of analysis into just minutes, leveraging an end-to-end AI architecture. The platform offers auto-scaling storage and GPU compute capabilities, resulting in analysis that is 30-50% more accurate. Designed with scientists in mind, it provides a user-friendly interface that enables clinicians to efficiently upload, analyze, and download data at a single-cell level, complete with publication-ready graphs. Additionally, Biodock processes millions of cells weekly for its academic and enterprise customers, contributing to the creation of a vast image dataset that enhances its competitive edge in the market.

Komodo Health is a healthcare technology company that provides a data-driven platform for real-world health information and insights. Its Healthcare Map aggregates diverse patient data to enable real-time intelligence across patients, clinicians, and health systems. The software suite includes Aperture, Pulse, and Serenity, which reveal intricate connections, highlight opportunities to influence disease burden, and analyze patient cohorts to generate actionable insights. The platform applies artificial intelligence and advanced data science to deliver patient-level analytics to life sciences companies, payers, providers, and other stakeholders. By delivering transparency and market intelligence, Komodo Health supports decision-making aimed at closing care gaps, reducing disease burden, and enabling more value-driven care. The company was founded in 2014 and is headquartered in New York with an additional office in San Francisco.

Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.

BioAge Labs develops medicines to treat aging and age-related diseases using its proprietary BioAge platform, which combines systems biology and AI. Its pipeline includes BGE-117 for multiple aging-related conditions, BGE-175 for immune aging and respiratory infections, and azelaprag for obesity in the elderly.

Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.

PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

Nautilus Biotechnology is a life sciences company developing platform technology to quantify and unlock the complexity of the human proteome. It aims to revolutionize proteomics, accelerate drug development, and improve healthcare management by democratizing access to the proteome.

Topography Health facilitates private practice physicians' involvement in clinical trials. It assists practices in understanding patient populations, recommends suitable studies, recruits patients, and manages research staff, making personalized clinical trials more accessible.

Founded in 2018, Tomorrow Health operates an online marketplace for medical supplies and equipment. It connects providers, health plans, and suppliers to ensure patients receive necessary products and care at home.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

Komodo Health is a healthcare technology company that provides a data-driven platform for real-world health information and insights. Its Healthcare Map aggregates diverse patient data to enable real-time intelligence across patients, clinicians, and health systems. The software suite includes Aperture, Pulse, and Serenity, which reveal intricate connections, highlight opportunities to influence disease burden, and analyze patient cohorts to generate actionable insights. The platform applies artificial intelligence and advanced data science to deliver patient-level analytics to life sciences companies, payers, providers, and other stakeholders. By delivering transparency and market intelligence, Komodo Health supports decision-making aimed at closing care gaps, reducing disease burden, and enabling more value-driven care. The company was founded in 2014 and is headquartered in New York with an additional office in San Francisco.

Founded in 2019, Genesis Therapeutics is a biotechnology company based in South San Francisco, California. It specializes in developing small molecule drug candidates for treating debilitating disorders using artificial intelligence-driven platforms.

Tmunity Therapeutics, Inc. is a biotherapeutics company based in Philadelphia, Pennsylvania, that specializes in the development of innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. Founded in 2015, Tmunity focuses on harnessing the potential of T cells through novel technologies, including T Cell Receptor (TCR) engineered T cells and regulatory T cells (Treg). The company has developed advanced platforms that allow for precise control over T cell activation and direction in vivo, as well as proprietary methods for activating, expanding, and genetically engineering T cells sourced from peripheral blood, cord blood, and tumors. Tmunity aims to advance personalized next-generation immunotherapies and has a team of experts with extensive experience in T-cell biology and clinical development, enhancing its capability to conduct safe and effective clinical trials. Its robust manufacturing platform supports multi-center clinical studies across various therapeutic areas, positioning Tmunity at the forefront of immunotherapy innovation.

Incredible Health, Inc. is a technology company based in San Francisco that operates a platform designed to connect healthcare providers, particularly hospitals, with qualified nursing professionals. Established in 2015 and originally known as Lift League, the company focuses on addressing staffing challenges in the healthcare sector. Its online recruitment platform employs AI technology to match healthcare systems with experienced nurses seeking permanent positions, particularly for hard-to-fill roles. The platform also features a subscription-based job portal that allows users, including new graduates and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Through its services, Incredible Health aims to enhance the employment experience for healthcare professionals and support healthcare organizations in fulfilling their staffing needs.

BioAge Labs develops medicines to treat aging and age-related diseases using its proprietary BioAge platform, which combines systems biology and AI. Its pipeline includes BGE-117 for multiple aging-related conditions, BGE-175 for immune aging and respiratory infections, and azelaprag for obesity in the elderly.

Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Founded in 2018, Scribe Therapeutics specializes in engineering and developing in vivo therapies based on CRISPR technology to rewrite and repair genetic disorders. Its proprietary platform, X-Editing (XE), enables greater efficacy, specificity, and deliverability compared to existing CRISPR technologies.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.

BioAge Labs develops medicines to treat aging and age-related diseases using its proprietary BioAge platform, which combines systems biology and AI. Its pipeline includes BGE-117 for multiple aging-related conditions, BGE-175 for immune aging and respiratory infections, and azelaprag for obesity in the elderly.

Shield Bio is a biotechnology company focused on combating antibiotic resistance, a growing public health crisis projected to surpass cancer-related deaths by 2050. The company has developed a novel genomic testing platform that enables sexually transmitted infection (STI) clinics to accurately identify antibiotic-resistant strains of pathogens, particularly gonorrhea, which has shown resistance to multiple antibiotics. With approximately 820,000 new gonorrhea infections annually in the United States and the Centers for Disease Control and Prevention designating resistant strains as an urgent threat, Shield Bio's rapid and precise molecular antibiotic susceptibility testing is critical. This platform allows healthcare providers to determine the most effective antibiotics for treatment, thereby enhancing patient outcomes and helping to curb the spread of antibiotic resistance.

PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

Jungla Inc., established in 2016 and headquartered in South San Francisco, is a biotechnology company specializing in molecular function software for healthcare and pharmaceutical industries. It optimizes disease diagnosis by developing advanced functional genomics, computational biophysics, and computer science technologies. Jungla's platform proactively assesses genetic variant risks, providing quantitative insights to complement observational data. This enhances clinical genetic testing accuracy and delivers robust, scalable results. As of July 2019, Jungla operates as a subsidiary of Invitae Corporation.

Cardiogram, Inc. is a San Francisco-based company founded in 2015 that specializes in developing a wearable device for monitoring heart health. The company's application allows users to analyze and visualize their heart rate measurements, tracking responses to various activities such as exercise, stress, and dietary changes. By detecting heartbeats and monitoring sleep and fitness patterns, Cardiogram aims to empower users to prevent serious cardiovascular issues, including strokes. The application is compatible with devices equipped with heart rate monitors, such as the Apple Watch and Android Wear, and facilitates the sharing of heart rate data through various social media platforms.

Halo Neuro, established in 2013 and headquartered in San Francisco, specializes in developing neurotechnology systems. Its flagship product, Halo Sport, employs a technique called Neuropriming, which combines electrical stimulation with movement-based training to enhance skill and strength acquisition in elite athletes. This process temporarily boosts the brain's learning capacity, or 'hyperplasticity', refining its ability to adapt to training. The company aims to help individuals unlock their full potential through innovative brain stimulation technology.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Human API is a health data network that facilitates the real-time sharing and viewing of health information across various platforms. Founded in 2013 and headquartered in San Mateo, California, the company connects consumers with their health data from a wide range of sources, including 90% of US hospitals, electronic medical records, pharmacies, labs, and over 300 wearable devices and wellness applications. The platform utilizes a machine learning-powered data pipeline to structure health data into a consistent format, making it accessible for medical researchers and scientists. Importantly, Human API empowers consumers by giving them full control over the sharing of their health information, while also providing companies with a streamlined method to access fragmented health data.

SolveBio is a contextual knowledge hub that specializes in genomic intelligence, aimed at supporting pharmaceutical, biotechnology, and diagnostic organizations. The company offers a platform designed to manage, distribute, and access genomic reference data at scale, facilitating the integration of both external and internal genomic information. This platform enables clients to leverage valuable third-party data assets, thereby driving innovation in precision medicine and advancing human health. By providing a real-time dynamic interface, SolveBio empowers organizations to effectively utilize genomic information in their research and development efforts.

Human API is a health data network that facilitates the real-time sharing and viewing of health information across various platforms. Founded in 2013 and headquartered in San Mateo, California, the company connects consumers with their health data from a wide range of sources, including 90% of US hospitals, electronic medical records, pharmacies, labs, and over 300 wearable devices and wellness applications. The platform utilizes a machine learning-powered data pipeline to structure health data into a consistent format, making it accessible for medical researchers and scientists. Importantly, Human API empowers consumers by giving them full control over the sharing of their health information, while also providing companies with a streamlined method to access fragmented health data.

CrowdMed, Inc. is a San Francisco-based company that leverages a prediction market technology to assist in diagnosing complex medical conditions. Founded in 2012, CrowdMed aims to provide patients with streamlined access to diagnostic information for their undiagnosed and chronic symptoms. The company's platform connects patients with a diverse network of medical detectives, including licensed physicians, medical students, and other healthcare professionals, who collaborate to generate diagnostic suggestions. By harnessing the collective intelligence of these experts, CrowdMed offers a collaborative solution for individuals facing unresolved medical issues, ultimately aiming to reduce healthcare costs while maintaining quality care. The platform is designed to empower patients by providing them with insightful answers to their medical challenges through the speed and convenience of online interaction.

Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.